132 related articles for article (PubMed ID: 31893351)
1. Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort.
Osterman E; Mezheyeuski A; Sjöblom T; Glimelius B
Ann Surg Oncol; 2020 Apr; 27(4):1036-1045. PubMed ID: 31893351
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting oncologic outcomes in patients with fewer than 12 lymph nodes retrieved after curative resection for colon cancer.
Huh JW; Kim CH; Kim HR; Kim YJ
J Surg Oncol; 2012 Feb; 105(2):125-9. PubMed ID: 21837680
[TBL] [Abstract][Full Text] [Related]
3. Effect of Lymph Node Retrieval and Ratio on the Long-Term Survival and Recurrence of Colon Cancer.
Rao A; Dadras M; Razzak MA; Ahmad K; Vijayasekar C
J Coll Physicians Surg Pak; 2016 Jun; 26(6):467-70. PubMed ID: 27353981
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes.
Jakob MO; Guller U; Ochsner A; Oertli D; Zuber M; Viehl CT
BMC Surg; 2018 Oct; 18(1):81. PubMed ID: 30285691
[TBL] [Abstract][Full Text] [Related]
5. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery.
Occhionorelli S; Andreotti D; Vallese P; Morganti L; Lacavalla D; Forini E; Pascale G
World J Surg Oncol; 2018 Sep; 16(1):186. PubMed ID: 30213260
[TBL] [Abstract][Full Text] [Related]
6. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
Sargent DJ; Resnick MB; Meyers MO; Goldar-Najafi A; Clancy T; Gill S; Siemons GO; Shi Q; Bot BM; Wu TT; Beaudry G; Haince JF; Fradet Y
Ann Surg Oncol; 2011 Nov; 18(12):3261-70. PubMed ID: 21533822
[TBL] [Abstract][Full Text] [Related]
8. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
9. Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer.
Dolan RD; McSorley ST; Horgan PG; McMillan DC
Medicine (Baltimore); 2018 Mar; 97(13):e0185. PubMed ID: 29595652
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
11. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
[TBL] [Abstract][Full Text] [Related]
12. [The significance of the preoperative CEA value for the prognosis of rectal cancer].
Mentges B; Brückner R; Weiss C
Langenbecks Arch Chir; 1990; 375(2):106-11. PubMed ID: 2329893
[TBL] [Abstract][Full Text] [Related]
13. Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma?
Gleisner AL; Mogal H; Dodson R; Efron J; Gearhart S; Wick E; Lidor A; Herman JM; Pawlik TM
J Am Coll Surg; 2013 Dec; 217(6):1090-100. PubMed ID: 24045143
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection.
Parnaby CN; Scott NW; Ramsay G; MacKay C; Samuel L; Murray GI; Loudon MA
Br J Cancer; 2015 Jul; 113(2):212-9. PubMed ID: 26079302
[TBL] [Abstract][Full Text] [Related]
15. Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.
Sargent DJ; Shi Q; Gill S; Louvet C; Everson RB; Kellner U; Clancy TE; Pipas JM; Resnick MB; Meyers MO; Wu TT; Huntsman D; Validire P; Farooq U; Pavey ES; Beaudry G; Haince JF; Fradet Y
Clin Cancer Res; 2014 Aug; 20(16):4361-9. PubMed ID: 24919572
[TBL] [Abstract][Full Text] [Related]
16. Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients.
Harrison LE; Guillem JG; Paty P; Cohen AM
J Am Coll Surg; 1997 Jul; 185(1):55-9. PubMed ID: 9208961
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
[TBL] [Abstract][Full Text] [Related]
18. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
[TBL] [Abstract][Full Text] [Related]
19. Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.
Osterman E; Glimelius B
Dis Colon Rectum; 2018 Sep; 61(9):1016-1025. PubMed ID: 30086050
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Recurrence in Patients with Stage III Colon Cancer Using Conventional Clinicopathological Factors and Peripheral Blood Test Data: A New Analysis with Artificial Intelligence.
Kamei Y; Takayama T; Suzuki T; Furihata K; Otsuki M; Sadahiro S
Oncology; 2021; 99(5):318-326. PubMed ID: 33626534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
